3B BLACKBIO DX LTD. Valuation
3BBLACKBIO · Healthcare · Current price ₹1,250.4
Is 3B BLACKBIO DX LTD. undervalued?
DocStoX estimates the fair value of 3B BLACKBIO DX LTD. at ₹1,577 per share, versus the current market price of ₹1,250. That puts the stock about +26.1% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹501), Relative P/E (₹4,182), Graham floor (₹762). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹501 (bear) to ₹1,577 (base) to ₹4,182 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
3B BLACKBIO DX LTD. trades at a P/E of 18.3x and a P/B of 3.2x. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on 3B BLACKBIO DX LTD.
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.